IntelligentMDx is pleased to announce that Jerome P. Kenney has joined its Board of Directors.
Mr. Kenney currently serves as a senior advisor to BlackRock Financial Management. From 2002 to 2008, Mr. Kenney was a Vice-Chairman and member of the Executive Client Coverage Group of Merrill Lynch & Co., Inc. From 1990 to 2002, Mr. Kenney served as the head of Corporate Strategy, Business Development and Research, and oversaw Corporate Credit, Marketing and Government Relations at Merrill Lynch. From 1985 to 1991, he served as President and Chief Executive Officer of the Merrill Lynch Capital Markets Group and as a member of the Board of Directors of Merrill Lynch.
Mr. Kenney holds a B.A. in Economics from Yale University and an M.B.A. in Finance from Northwestern University's Kellogg School of Management.
About IMDx
Based in Cambridge, MA, IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics. IMDx’s expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by IMDx’s proprietary bioinformatics and product development processes allowing for the rapid design and development of tests to meet clinical needs.